Inscripta is a life science technology company that develops digital genome engineering solutions.
Inscripta has raised $4.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2023.
Inscripta's investors include Oak HC/FT, Venrock, Foresite Capital, Fidelity, Paladin Capital Group.
Inscripta is headquartered in Pleasanton, United States.
Inscripta is a life science technology company that develops digital genome engineering solutions.
Inscripta is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inscripta — Funding & Investors." VCBacked, January 18, 2023, https://www.vcbacked.co/company/inscripta. Accessed July 21, 2026.
VCBacked. (2023). Inscripta — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/inscripta
{{cite web |title=Inscripta — Funding & Investors |url=https://www.vcbacked.co/company/inscripta |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated